Philips Respironics has removed certain DreamStation devices due to programming errors that can result in failed therapy modes, according to the U.S. Food and Drug Administration.

The U.S. District Court for the Western District of Pennsylvania restricted Philips Respironics from producing and selling new respiratory devices from several facilities in the U.S., the FDA said ...

One of the nation's largest makers of machines for sleep apnea sufferers has agreed to pay $479 million to compensate customers who bought the devices and suffered injuries due to foam spewing into ...

The U.S. Department of Health and Human Services recently terminated multiple contracts to add ventilators to the country’s Strategic National Stockpile. And, while federal health officials say they ...

Amsterdam, the Netherlands - Following the FDA’s inspection of Philips Respironics’ facility in Murrysville in 2021 and the subsequent inspectional observations, the US Department of Justice (DOJ), ...

Philips Respironics must hire independent experts to inspect facilities and products and hand over part of its revenue to the U.S. Treasury under a proposed consent decree filed in U.S. District Court ...

A company that makes breathing masks for people with sleep apnea has agreed to pay $34.8 million to settle claims it paid kickbacks to suppliers that sold its products.Philips Respironics Inc. of ...

The Food and Drug Administration (FDA) sent a warning notice to Philips Respironics after patients and medical suppliers claimed they were unaware that certain breathing assistance machines had been ...

Philips agreed with insurers to pay Philips 540 million euros to cover Respironics recall-related product liability claims. Philips Respironics has agreed to pay $1.1 billion; the related payments are ...

Dutch medical device maker Philips said Monday it had reached a $1.1 billion deal in the United States to settle lawsuits over faulty sleep machines in a case that have dogged the company. The company ...

TOKYO--(BUSINESS WIRE)--Philips Respironics GK (Headquartered in Minato Ward of Tokyo, hereafter Philips, CEO Danny Risberg) announced today that, beginning April 1, 2014, they are starting sales of a ...

In June of 2021, Philips Respironics issued a recall for some of its CPAP and BiPAP machines. Now the U.S. Food and Drug Administration says the notification to users about the recall “have been ...